A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-3211
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list ; volume:15 ; number:1 ; day:8 ; month:12 ; year:2022 ; pages:1-11 ; date:12.2022
Journal of pharmaceutical policy and practice ; 15, Heft 1 (8.12.2022), 1-11, 12.2022
- Creator
-
Naicker, Ian
Suleman, Fatima
Perumal-Pillay, Velisha Ann
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40545-022-00494-0
- URN
-
urn:nbn:de:101:1-2023021809043810842561
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Naicker, Ian
- Suleman, Fatima
- Perumal-Pillay, Velisha Ann
- SpringerLink (Online service)
Other Objects (12)
Associations between essential medicines and health outcomes for cardiovascular disease
Revising the WHO Essential Medicines List for paediatric rheumatology
Improving quality of essential medicines : a biowaiver approach
Revising the WHO Essential Medicines List for paediatric rheumatology update
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
Three essays on the procurement of essential medicines in developing countries
Quantitative evaluation of essential medicines lists: the South African case study
Three Essays on the Procurement of Essential Medicines in Developing Countries
Associations between essential medicines and health outcomes for cardiovascular disease
Revising the WHO Essential Medicines List for paediatric rheumatology
Improving quality of essential medicines : a biowaiver approach
Revising the WHO Essential Medicines List for paediatric rheumatology update
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
Three essays on the procurement of essential medicines in developing countries
Quantitative evaluation of essential medicines lists: the South African case study
Three Essays on the Procurement of Essential Medicines in Developing Countries
Associations between essential medicines and health outcomes for cardiovascular disease
Revising the WHO Essential Medicines List for paediatric rheumatology
Improving quality of essential medicines : a biowaiver approach
Revising the WHO Essential Medicines List for paediatric rheumatology update
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Biologic medicine inclusion in 138 national essential medicines lists
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
Three essays on the procurement of essential medicines in developing countries
Quantitative evaluation of essential medicines lists: the South African case study